MOH Medical Device Registration and Authorized Representative Kuwait
Enter one of the Gulf's fastest modernising healthcare markets now governed by the new Ministerial Decree 387/2025. NexorTest delivers end-to-end Kuwait MOH registration: Class A-D registration for medical devices and IVDs, the Standard, Fast Track and Abridged (reliance based) review pathways, local Authorized Representative coordination, and IMDRF aligned STED dossiers all under one expert roof.
Four Risk Based Device Classes Under MOH Decree 387/2025
Kuwait applies a single IMDRF aligned, risk based framework to both medical devices and IVDs based on intended use, body contact, invasiveness, and duration. Your class determines the review pathway, documentation, and timeline.
Class A Devices
Lowest risk devices such as surgical retractors, examination gloves, and reusable instruments. Lightest documentation burden and the most streamlined STED review.
- Reduced STED
- AR Required
- Fastest Review
Class B Devices
Low to moderate risk devices such as hypodermic needles, suction equipment, and blood administration sets. STED dossier and ISO 13485 evidence expected.
- STED File
- ISO 13485
- All 3 Pathways
Class C Devices
Moderate to high risk devices including ventilators, infusion pumps, and dialysis machines. Clinical and performance evidence required in a full STED dossier.
- Clinical Evidence
- Full STED
- Benefit Risk
Class D Devices
Highest risk devices such as cardiac stents, implantable defibrillators, and heart valves. Subject to the most rigorous MOH technical review and documentation.
- Stringent Review
- Clinical Data
- Legalized Docs
Three Pathways to Your MOH Registration Kuwait
Decree 387/2025 created three review pathways. Choosing the right one based on your existing approvals and device class is the single biggest lever on your Kuwait timeline. Eligibility is at MOH discretion and not automatic.
MOH Registration Kuwait
Leverage an existing approval from a reference authority US FDA, EU CE (MDR/IVDR), UK MHRA, Health Canada, TGA, PMDA, or ANVISA. Submit a reduced dossier under the MOH’s reliance framework. The Kuwait market device should match the reference-market version, cutting redundant review and accelerating market entry.
Fast Track Review
Reserved for critical, ICU, life saving, or Central Medical Stores (CMS) requested products. A CMS supply contract or request acts as a priority trigger that moves your file ahead of the standard queue. Ideal for urgent public health and tender driven supply.
Standard Review
Full technical STED dossier submitted directly to the MMPRRA for complete review. Required for devices without an eligible reference approval. Timeline scales with class and complexity from moderate for lower risk devices to longer for complex Class D submissions.
Comprehensive Kuwait Regulatory Services
From classification and Authorized Representative coordination through post-market surveillance, NexorTest manages every aspect of your Kuwait MOH registration and lifecycle.
MOH Sanitary Registration
Complete MOH registration for Class A, B, C, and D medical devices and IVDs. We manage classification, pathway selection, STED dossier preparation, MMPRRA submission, fee payment, application tracking, and query resolution end to end.
Local Authorized Representative
Coordination of a compliant, MOH approved Kuwait Authorized Representative holding the required Ministry of Commerce, Agent, and Store licenses acting as your official point of contact before the MOH for registration, imports, and vigilance.
Abridged Reliance Submissions
We map your FDA, CE, MHRA, Health Canada, TGA, PMDA, or ANVISA approval onto Kuwait's Abridged pathway, build the reduced reliance dossier, demonstrate equivalence, and target the fastest compliant MOH review.
Fast Track & CMS Coordination
For critical, ICU, and life saving devices, we structure submissions around Central Medical Stores requests and supply contracts to trigger the Fast Track pathway and move your file ahead of the standard queue.
STED Dossier Preparation
IMDRF aligned Summary Technical Documentation: device description, Essential Principles checklist, risk management (ISO 14971), benefit risk analysis, clinical and performance evidence, labelling, and Instructions for Use built for first cycle approval.
Document Legalization
Coordination of Free Sale Certificate, ISO 13485, CE certificate, and Letter of Authorization legalization via the Kuwait or authorized GCC embassy or e-legalization where official electronic verification is available.
IVD Registration Kuwait
In Vitro Diagnostic registration under the Class A-D framework, including analytical and clinical performance evaluation, reagent and labeling documentation, and Abridged-pathway submissions for IVDs already approved by a reference authority.
SaMD & Digital Health
Software as a Medical Device strategy for Kuwait: software lifecycle and validation documentation (IEC 62304), cybersecurity risk assessment, AI/ML evidence, and registration aligned with the MOH's evolving digital health expectations.
Post-Market Surveillance & Renewals
PMS and vigilance systems: adverse event and recall reporting to the MOH, global safety action notifications, plus renewals, variations, and agency transfer support to keep your registrations current and compliant.
Why Manufacturers Choose Us for Kuwait Market Entry
We work to the current Decree 387/2025 framework with reliance route expertise and a vetted MOH approved agent network turning one dossier into Gulf wide market access.
Decree 387/2025 Specialists
We work to the current MMPRRA framework three pathways, IMDRF aligned STED, and strict local agent rules not the outdated 13/2022 process many competitors still describe.
Reliance & Abridged Route Experts
We turn your FDA, CE, or MHRA approval into a reduced Abridged submission, leveraging Kuwait's reference authority reliance framework to cut months off Standard Review.
MOH Approved Agent Network
Vetted local Authorized Representatives with the correct Ministry of Commerce, Agent, and Store licenses so foreign manufacturers stay compliant without setting up a Kuwait entity.
One Partner for GCC & Global Access
Coordinate Kuwait alongside Saudi SFDA, UAE, Qatar, Bahrain, Oman, US FDA, and EU MDR/CE from a single integrated program turning one dossier into Gulf wide market access.
Transparent Fixed Fee Packages
Our fixed fee scopes cover strategy, AR coordination, STED dossier, submission, and post-market support, with clear milestones and deliverables.
Six Steps to Your Kuwait MOH Registration
A proven, structured approach that minimizes MOH queries and accelerates your path to the Kuwaiti medical device market.
Classification & Pathway Strategy
We confirm your device or IVD class (A, B, C, or D) under Decree 387/2025 and select the optimal pathway Standard, Fast Track, or Abridged based on your existing FDA, CE, MHRA, or other reference authority approvals.
Appoint Local Authorized Representative
We appoint and coordinate a compliant, MOH approved Kuwait AR with the required Ministry of Commerce, Agent, and Store licenses to act as your official point of contact before the MOH.
STED Dossier Preparation
We compile the IMDRF aligned STED file device description, Essential Principles checklist, risk management (ISO 14971), clinical/performance data and legalize the Free Sale Certificate, ISO 13485, and CE documents.
Pre-Submission QC & Bundling
We run a deficiency prevention quality check, confirm bundling eligibility (up to 50 items per application), and finalise the reliance evidence for the Abridged pathway where applicable.
MMPRRA Submission & Query Management
We submit to the Medicine and Medical Products Registration and Regulatory Administration, pay government fees, track the application, and manage every MOH query and deficiency response to keep the clock moving.
MOH Registration & Post-Market Support
You receive your MOH registration. We set up post-market surveillance and vigilance reporting and manage renewals, variations, and agency transfers to keep you compliant.
Kuwait MOH Expertise Across Every Device Category
From implantables to digital health, our regulatory specialists cover the full breadth of medical technology entering the Kuwaiti market.
- 🧬 In Vitro Diagnostics
- 💻 SaMD & Digital Health
- 🩻 Imaging & Radiology
- 🦴 Orthopaedics
- 💉 Infusion & Drug Delivery
- 🩸 Surgical Instruments
- 👁 Ophthalmics
- 🦷 Dental Devices
- 🏥 Electro-Medical Equipment
- 🫀 Cardiovascular & Implants
- 🧪 Laboratory Equipment
- 📱 Wearables & Remote Monitoring
Frequently Asked Questions for Medical Device Registration Kuwait
Who regulates medical devices in Kuwait?
Medical devices and IVDs in Kuwait are regulated by the Ministry of Health (MOH) through the Medicine and Medical Products Registration and Regulatory Administration (MMPRRA). The current framework is set by Ministerial Decree No. 387 of 2025, which replaced earlier decrees and applies a single risk based framework to both medical devices and IVDs. All devices must hold a valid MOH registration before importation, marketing, or distribution in Kuwait, for both the public and private sectors. The process involves classification (Class A-D), appointment of a local Authorized Representative for foreign manufacturers, STED dossier preparation, and submission via the Standard, Fast Track, or Abridged pathway.
How are devices classified under Decree 387/2025?
Kuwait uses an IMDRF aligned, risk based system with four classes. Class A covers low risk devices (surgical retractors, examination gloves, reusable instruments). Class B covers low-to-moderate risk devices (hypodermic needles, suction equipment, blood administration sets). Class C covers moderate to high risk devices (ventilators, infusion pumps, dialysis machines). Class D covers high risk devices (cardiac stents, implantable defibrillators, heart valves). IVDs are independently classified A-D. Classification is based on intended use, duration of use, invasiveness, and risk, and it determines documentation depth, the review pathway, and the timeline.
Is a local Authorized Representative required in Kuwait?
Yes, Every foreign manufacturer must appoint a local Authorized Representative (AR) established in Kuwait. The AR must be a legal entity holding a valid Ministry of Commerce license plus an Agent License and Store License from the Pharmaceutical Inspection and Licensing Administration, and must be approved by the MOH for medical device activities. The AR represents the manufacturer for registration, importation approvals, post-market surveillance, regulatory communication, and variations. NexorTest coordinates compliant, MOH approved local Authorized Representatives and manages the relationship on your behalf, so you retain control of your registrations.
What registration pathways does Kuwait MOH offer?
Decree 387/2025 introduces three pathways. The Standard Review is a full technical STED dossier review for all classes. The Fast Track Review is reserved for critical, ICU, life saving, or Central Medical Stores (CMS) requested products, where a supply contract or CMS request acts as a priority trigger. The Abridged Review is a reliance based route that leverages approvals from reference authorities such as US FDA, EU CE, UK MHRA, Health Canada, TGA, PMDA, and ANVISA. Pathway eligibility is subject to MOH discretion and is not granted automatically. NexorTest selects and justifies the fastest compliant pathway for each product.
How long does Kuwait registration take?
Timelines depend on the pathway and class. The Abridged (reliance based) Review targets approximately 3-6 months for qualifying devices already approved by a reference authority. The Standard Review typically runs approximately 6-9 months for a full technical dossier. The Fast Track Review is case dependent and expedited for critical, ICU, life saving, or CMS requested products. Actual timelines depend on dossier quality, classification, and how quickly MOH queries are resolved. NexorTest targets first cycle approvals by submitting complete, STED compliant dossiers that minimise deficiency queries.
What technical documentation does Kuwait require?
Kuwait requires a Summary Technical Documentation (STED) file aligned with IMDRF device description and intended use, risk classification justification, an Essential Principles checklist, risk management and benefit risk analysis (ISO 14971), clinical evidence or performance data, labelling and Instructions for Use, and ISO 13485 certification and/or referenceauthority approvals. Supporting documents such as the Free Sale Certificate, ISO 13485 certificate, CE certificate, and Letter of Authorization must be legalized by the Kuwait Embassy or an authorized GCC embassy, unless valid electronic verification is available. NexorTest prepares and quality checks the complete STED dossier before submission.
Can existing FDA or CE approvals speed up registration?
Yes, Kuwait’s Abridged Review pathway is reliance based and recognises approvals from reference authorities including US FDA (CDRH), EU CE Marking (MDR/IVDR), UK MHRA (UKCA), Health Canada, TGA Australia, PMDA/MHLW Japan, and ANVISA Brazil. Leveraging these approvals lets manufacturers submit a reduced dossier and can shorten timelines and reduce redundant testing. The Kuwait market device should match the reference market version. NexorTest maps your existing approvals onto the optimal reliance pathway to accelerate market entry.
Can multiple products be registered under one application?
Yes, subject to bundling rules. Devices may be grouped as a Medical Device Family, Medical Device System, Procedure Pack, or IVD Device Pack, with a maximum of 50 items per application subject to MOH acceptance. Correct bundling optimises both cost and timelines. NexorTest evaluates bundling eligibility before submission so you consolidate related products into the fewest compliant applications.
Ready to Enter the Kuwait Medical Device Market?
Get a free Kuwait regulatory assessment under MOH Decree 387/2025. Our specialists will map your fastest compliant pathway including the Abridged reliance route to an MOH registration.